Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Late-breaking news from the ICAAC: GS-4104 reduces suffering and complications in flu patients

Sep. 28, 1998

Preclinical data and clinical findings reported for Lilly echinocandin

Sep. 28, 1998

BMS-207147 considered good candidate for clinical trials in human mycoses

Sep. 28, 1998

UR-9825 compared to itraconazole and fluconazole for activity against yeasts

Sep. 28, 1998

Comparative in vitro and in vivo activity of WQ-3034 reported at ICAAC

Sep. 28, 1998

Xoma presents new BPI-related findings and Neuprex phase II data at ICAAC

Sep. 28, 1998

Parasin I: new antimicrobial peptide produced by catfish

Sep. 28, 1998

More new azolylphenyl oxazolidinones in development at P&U

Sep. 28, 1998

Modifications to the linezolid molecule a focus of research at Pharmacia & Upjohn

Sep. 28, 1998

P&U explores modifications to linezolid; new, more active oxazolidinones result

Sep. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.